RESTON, Va., Feb. 8, 2016 -- Constellis, a leading provider of operational support and risk management services, announced today that Triple Canopy (a Constellis company) has been awarded a seven-year, multiple award indefinite delivery/indefinite quantity (MAIDIQ) Department of Defense (DoD) Counter Narcotics and Global Threats (CN>) contract by the Air Combat Command Acquisition Management and Integration Center (AMIC) for operations and logistic support services.
With a maximum ceiling of $975M, the IDIQ contract supports the Deputy Assistant Secretary of Defense (DASD) for the DoD's CN> requirements providing operations, logistics, and construction services. Primes include nine large businesses and six small businesses awardees. Work will be performed globally with a period of performance to be complete by January 28, 2025.
"Constellis is honored to support the DoD's CN> mission by providing trusted operations and logistic services around the world," said Jason DeYonker, CEO of Constellis. "This contract is critical in establishing a secure and stable global security environment for our customers to work and thrive, and we are proud to have an important role in ensuring their continuity of operations and success."
DoD Press Release No: CR-018-16 on February 1, 2016
About Constellis
Constellis is a leading provider of operational support and risk management services to government and commercial clients worldwide. From logistics, life support and security to advisory, training and technology services, we offer a full range of program and risk management solutions to help organizations conduct business safely and efficiently no matter where they are in the world. With more than 8,000 personnel, we leverage our operational excellence, comprehensive expertise, world-class facilities and global network of partners to quickly deliver tailored, cost-effective and innovative services to our clients. For more information, visit www.constellis.com, or join us on LinkedIn and Twitter (@Constellis).
CONTACT: Katy Pultz
Sr. Manager, Marketing & Communications
[email protected]
+1 703 673 5154


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 



